NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
Peaknorepinephrine bitartrate
NDAINTRAVENOUSSOLUTION
Approved
Oct 2022
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
(alpha-adrenergic action) and an inotropic stimulator of the heart and dilator of coronary arteries (beta-adrenergic action).
Loss of Exclusivity
LOE Date
Jan 30, 2038
144 months away
Patent Expiry
Jan 30, 2038